Announce Date | 03/26/2025 |
EPS Normalized Actual | $0.69 (Beat by $0.07) |
EPS GAAP Actual | $0.69 (Beat by $0.07) |
Revenue Actual | $2.0976B |
Revenue Surprise | Beat by $2097.6M |
Announce Date | 04/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.00792 |
EPS GAAP Estimate | $2.00792 |
Revenue Estimate | $1.732029098B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2028 | 6.44131 | 5.77 | 6.07372 | 6.78761 | 16 |
Jan 2027 | 14.2174 | 2.61 | 13.9368 | 14.99081 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | -11.42 | -14.07398 | 2.0976B | 100% | -507.51M |
FQ4 2024 (Oct 2024) | 0 | -2.23489 | 1.9557B | 100% | -339.8M |
FQ2 2012 (Apr 2012) | 0.46 | 0.46 | 0.7627B | 100% | 762.7M |
FQ3 2012 (Jul 2012) | -0.0237 | -0.0237 | 0.6081B | 100% | 608.1M |
FQ4 2012 (Oct 2012) | 0.27 | 0.27 | 0.7339B | 100% | 733.9M |
FQ1 2013 (Jan 2013) | 0.3 | 0.3 | 0.7915B | 100% | 791.5M |
FQ3 2023 (Jul 2023) | 0 | 0 | 2.778B | 12.22% | 2778M |
FQ2 2023 (Apr 2023) | 1.96 | 1.96 | 2.4294B | 100% | 2429.4M |
FQ4 Announce Date
04/30/2025 (Pre-Market)
Consensus EPS Estimates
2.00792
Consensus Revenue Estimates
1.732029098B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 3.43504 | -- | 3.15752 | 3.86393 | 0 |
FQ4 2026 (Oct 2026) | 2.96338 | -- | 2.72397 | 3.33338 | 1 |
FQ3 2026 (Jul 2026) | 2.76455 | -- | 2.5412 | 3.10973 | 1 |
FQ2 2026 (Apr 2026) | 2.3552 | -- | 2.10277 | 2.67501 | 5 |
FQ1 2026 (Jan 2026) | 3.09746 | 468.69 | 2.84721 | 3.48421 | 1 |
FQ4 2025 (Oct 2025) | 2.68208 | -- | 2.46539 | 3.01696 | 1 |
FQ3 2025 (Jul 2025) | 2.06332 | -- | 1.89662 | 2.32094 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 3.01B | -- | 2.82B | 3.3B | 1 |
FQ4 2026 (Oct 2026) | 2.9B | -- | 2.72B | 3.18B | 2 |
FQ3 2026 (Jul 2026) | 2.8B | -- | 2.63B | 3.07B | 2 |
FQ2 2026 (Apr 2026) | 3.71B | -- | 3.4B | 4.1B | 3 |
FQ1 2026 (Jan 2026) | 2.74B | 23.56 | 2.57B | 3.01B | 2 |
FQ4 2025 (Oct 2025) | 2.43B | 19.39 | 2.28B | 2.66B | 0 |
FQ3 2025 (Jul 2025) | 2.44B | -- | 2.29B | 2.68B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 2.65398 | -11.42 | -14.07398 | 123.24% |
FQ4 2024 (Oct 2024) | 2.23489 | 0 | -2.23489 | -INF% |
FQ2 2012 (Apr 2012) | 0.46 | 0.46 | 100% | |
FQ3 2012 (Jul 2012) | -0.0237 | -0.0237 | 100% | |
FQ4 2012 (Oct 2012) | 0.27 | 0.27 | 100% | |
FQ1 2013 (Jan 2013) | 0.3 | 0.3 | 100% | |
FQ3 2023 (Jul 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Apr 2023) | 1.96 | 1.96 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $2.61B | $2.1B | $-507.51M | -24.19% |
FQ4 2024 (Oct 2024) | $2.3B | $1.96B | $-339.8M | -17.37% |
FQ2 2012 (Apr 2012) | $0B | $0.76B | $762.7M | 100% |
FQ3 2012 (Jul 2012) | $0B | $0.61B | $608.1M | 100% |
FQ4 2012 (Oct 2012) | $0B | $0.73B | $733.9M | 100% |
FQ1 2013 (Jan 2013) | $0B | $0.79B | $791.5M | 100% |
FQ3 2023 (Jul 2023) | $0B | $2.78B | $2778M | 100% |
FQ2 2023 (Apr 2023) | $0B | $2.43B | $2429.4M | 100% |